IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Medicxi Ventures Management (Jersey) Ltd

Q4 2023 Holdings

Filed 2024-02-01 | 5 holdings | $296.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Centessa Pharmaceuticals PLC(CNTA)SPONSORED ADS152309100$158.9M19,963,15753.6%
Merus N VCOMN5749R100$44.0M1,600,00014.9%
Phathom Pharmaceuticals Inc(PHAT)COM71722W107$34.3M3,760,86911.6%
Newamsterdam Pharma Company(NAMS)ORDINARY SHARESN62509109$32.1M2,869,56510.8%
Aura Biosciences Inc(AURA)COM05153U107$26.9M3,039,8929.1%